Jeffrey V. Poulton
Overview
Jeffrey V. Poulton received an average of $4M in total compensation, including $460K in salary, at Alnylam Pharmaceuticals from 2019 to 2021.
2021Alnylam PharmaceuticalsExecutive Vice President, Chief Financial Officer principal financial officer
2020Alnylam PharmaceuticalsExecutive Vice President, Chief Financial Officer principal financial officer
2019Alnylam PharmaceuticalsExecutive Vice President, Chief Financial Officer principal financial officer
Source: SEC filings on April 5, 2022 and April 2, 2021.
Related executives
We found 13 more executives who work or worked at Alnylam Pharmaceuticals.
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
Tolga Tanguler
Alnylam Pharmaceuticals
Executive Vice President, Chief Commercial Officer
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
Barry Greene
Alnylam Pharmaceuticals
Former President
Laurie Keating
Alnylam Pharmaceuticals
Chief Legal Officer
Manmeet Soni
Alnylam Pharmaceuticals
Chief Financial Officer
Michael Mason
Alnylam Pharmaceuticals